Minerva Neurosciences, IncMinerva Neurosciences, IncMinerva Neurosciences, Inc

Minerva Neurosciences, Inc

No trades
See on Supercharts

NERV fundamentals

Key facts

Market capitalization
Founded
CEO
Website
About

Minerva Neurosciences, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of a portfolio of product candidates to treat central nervous system diseases. It develops Roluperidone for the treatment of negative symptoms in patients with schizophrenia and MIN-301 for the treatment of Parkinson’s disease. The company was founded by Rogerio Vivaldi Coelho and Goeffrey Robin Race on April 23, 2007 and is headquartered in Burlington, MA.

Valuation

Fundamental metrics to determine fair value of the stock

Summary
No data available
There's currently no market capitalization, revenue or net income data to show.
Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

No dividends
NERV has never paid dividends and has no current plans to do so.

Financial health

Financial position and solvency of the company